Wedbush Securities’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Buy |
1,215
+508
| +72% | +$194K | 0.02% | 658 |
|
|
2025
Q1 | $244K | Sell |
707
-87
| -11% | -$30K | 0.01% | 912 |
|
|
2024
Q4 | $238K | Buy |
794
+127
| +19% | +$38.1K | 0.01% | 945 |
|
|
2024
Q3 | $271K | Sell |
667
-658
| -50% | -$267K | 0.01% | 846 |
|
|
2024
Q2 | $426K | Sell |
1,325
-25
| -2% | -$8.04K | 0.02% | 688 |
|
|
2024
Q1 | $450K | Buy |
+1,350
| New | +$450K | 0.02% | 684 |
|
|
2023
Q1 | – | Sell |
-874
| Closed | -$210K | – | 1099 |
|
|
2022
Q4 | $210K | Buy |
+874
| New | +$210K | 0.01% | 891 |
|
|
2022
Q2 | – | Sell |
-973
| Closed | -$244K | – | 1118 |
|
|
2022
Q1 | $244K | Buy |
973
+4
| +0.4% | +$1K | 0.01% | 898 |
|
|
2021
Q4 | $249K | Sell |
969
-69
| -7% | -$17.7K | 0.01% | 961 |
|
|
2021
Q3 | $252K | Buy |
1,038
+12
| +1% | +$2.91K | 0.01% | 950 |
|
|
2021
Q2 | $212K | Sell |
1,026
-42
| -4% | -$8.68K | 0.01% | 1033 |
|
|
2021
Q1 | $201K | Buy |
+1,068
| New | +$201K | 0.01% | 985 |
|
|
2020
Q2 | – | Sell |
-5,267
| Closed | -$473K | – | 980 |
|
|
2020
Q1 | $473K | Sell |
5,267
-120
| -2% | -$10.8K | 0.06% | 369 |
|
|
2019
Q4 | $796K | Buy |
5,387
+27
| +0.5% | +$3.99K | 0.07% | 316 |
|
|
2019
Q3 | $645K | Buy |
5,360
+52
| +1% | +$6.26K | 0.06% | 349 |
|
|
2019
Q2 | $717K | Sell |
5,308
-236
| -4% | -$31.9K | 0.07% | 311 |
|
|
2019
Q1 | $723K | Buy |
5,544
+844
| +18% | +$110K | 0.08% | 301 |
|
|
2018
Q4 | $585K | Buy |
+4,700
| New | +$585K | 0.07% | 306 |
|
|
2018
Q2 | – | Sell |
-5,247
| Closed | -$509K | – | 893 |
|
|
2018
Q1 | $509K | Buy |
5,247
+103
| +2% | +$9.99K | 0.07% | 361 |
|
|
2017
Q4 | $452K | Sell |
5,144
-90
| -2% | -$7.91K | 0.06% | 414 |
|
|
2017
Q3 | $417K | Sell |
5,234
-794
| -13% | -$63.3K | 0.05% | 448 |
|
|
2017
Q2 | $526K | Buy |
6,028
+88
| +1% | +$7.68K | 0.07% | 374 |
|
|
2017
Q1 | $529K | Buy |
5,940
+123
| +2% | +$11K | 0.07% | 344 |
|
|
2016
Q4 | $431K | Buy |
+5,817
| New | +$431K | 0.06% | 375 |
|